UBS Maintains Neutral on CryoPort, Lowers Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Dan Leonard maintains a Neutral rating on CryoPort (NASDAQ:CYRX) but lowers the price target from $17 to $7.
August 07, 2024 | 4:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
UBS analyst Dan Leonard maintains a Neutral rating on CryoPort but significantly lowers the price target from $17 to $7.
The significant reduction in the price target from $17 to $7 by UBS suggests a negative outlook on CryoPort's future performance. This is likely to put downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100